VELTASSA Trademark

Trademark Overview

On Friday, March 28, 2014, a trademark application was filed for VELTASSA with the United States Patent and Trademark Office. The USPTO has given the VELTASSA trademark a serial number of 86235807. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 29, 2022. This trademark is owned by Relypsa, Inc.. The VELTASSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, gastrointestinal and endocrine diseases or disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders
veltassa

General Information

Serial Number86235807
Word MarkVELTASSA
Filing DateFriday, March 28, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 29, 2022
Registration Number4933010
Registration DateTuesday, April 5, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of hyperkalemia; pharmaceutical preparations for the treatment and prevention of renal, cardiovascular, gastrointestinal and endocrine diseases or disorders; pharmaceutical preparations for reducing potassium levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of hyperkalemia and renal, cardiovascular, gastrointestinal, and endocrine disorders
Translation of Words in MarkThe wording "Veltassa" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 11, 2014
Primary Code005
First Use Anywhere DateMonday, December 21, 2015
First Use In Commerce DateMonday, December 21, 2015

Trademark Owner History

Party NameRelypsa, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameRelypsa, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063
Party NameRelypsa, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94063

Trademark Events

Event DateEvent Description
Thursday, September 29, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 29, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 29, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 4, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, April 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 5, 2016REGISTERED-PRINCIPAL REGISTER
Saturday, February 27, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 26, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 22, 2016ASSIGNED TO EXAMINER
Saturday, February 13, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, December 28, 2015USE AMENDMENT FILED
Tuesday, February 2, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 28, 2015TEAS STATEMENT OF USE RECEIVED
Friday, October 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 28, 2015SOU EXTENSION 2 GRANTED
Wednesday, October 28, 2015SOU EXTENSION 2 FILED
Wednesday, October 28, 2015TEAS EXTENSION RECEIVED
Thursday, June 18, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 18, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 24, 2015SOU EXTENSION 1 GRANTED
Friday, April 24, 2015SOU EXTENSION 1 FILED
Friday, April 24, 2015TEAS EXTENSION RECEIVED
Tuesday, October 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, August 13, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 31, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 31, 2014ASSIGNED TO LIE
Monday, July 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 1, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, July 1, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 1, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, July 1, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, June 30, 2014ASSIGNED TO EXAMINER
Friday, April 11, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 1, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

veltassa pharmaceutical preparations prevention treatment gastrointestinal disorders endocrine hyperkalemia renal cardiovascular